TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.70E+3nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.80E+3nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 3.10E+3nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 3.80E+3nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 4.10E+3nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 4.30E+3nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 4.70E+3nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 5.50E+3nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 6.70E+3nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 6.90E+3nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 7.30E+3nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 7.40E+3nMAssay Description:Compound was evaluated for inhibition of HIV-2 reverse transcriptase using rC.dG and [3H]-dGTP as substrates at 100 microg/mlMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 8.30E+3nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 8.50E+3nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 8.70E+3nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 8.70E+3nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 9.00E+3nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 9.00E+3nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 9.00E+3nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 9.00E+3nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 9.20E+3nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 9.60E+3nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.06E+4nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.20E+4nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.40E+4nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.40E+4nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.50E+4nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.50E+4nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.80E+4nMAssay Description:Compound was evaluated for inhibition of HIV-1 reverse transcriptase using rC.dG and [3H]-dGTP as substrates at 100 ug/mLMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.90E+4nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.90E+4nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 2.10E+4nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 3.20E+4nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 3.50E+4nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 6.60E+4nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 6.60E+4nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Compound was evaluated for inhibition of HIV-1 reverse transcriptase using rC.dG and [3H]-dGTP as substrates at 100 microg/mlMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Compound was evaluated for inhibition of HIV-2 reverse transcriptase using rC.dG and [3H]-dGTP as substrates at 100 ug/mLMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: >1.20E+5nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: >1.20E+5nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.20E+5nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair